Moderna sues Pfizer and BioNTech over Covid-19 vaccine The vaccine maker said it had filed patent infringement lawsuits in the US and Germany. The Independent UK · Aug 26, 2022
Moderna sues Pfizer/BioNTech alleging patent infringement over Covid vaccine Moderna seeks unspecified damages in lawsuit over rivals’ jab Evening Standard · Aug 26, 2022
Covid infections at lowest level in two months- ONS High levels of coronavirus antibodies among the population means the rate of serious illness remains low Evening Standard · Aug 26, 2022
NOT REAL NEWS: A look at what didn't happen this week Social media users shared a range of false claims this week The Independent UK · Aug 26, 2022
Thonburi Healthcare chairman resigns after market ban Dr Boon Vanasin, the founder and chairman of Thonburi Healthcare Group (THG), is resigning from the company’s board as he faces a market ban in connection with claims he made last year about the purchase of Pfizer coronavirus vaccines. Bangkok Post · Aug 26, 2022
Moderna sues Pfizer, BioNTech over COVID vaccine technology Moderna Inc. sued Pfizer Inc. and BioNTech SE, claiming the technology in their COVID-19 shot infringes on its patents, a move that sets the stage for a massive legal clash between the vaccine titans. Tribune News Service · Aug 26, 2022
Moderna sues Pfizer over Covid vaccine Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Bangkok Post · Aug 26, 2022
Moderna sues Pfizer over patents behind COVID-19 vaccine COVID-19 vaccine maker Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech, accusing the rivals of copying Moderna’s technology in order to make their own vaccine The Independent UK · Aug 26, 2022
Moderna sues Pfizer-BioNTech accusing them of copying Covid shot technology ‘We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,’ Moderna legal officer says The Independent UK · Aug 26, 2022
Is Pfizer a Buy Before New Omicron Boosters Roll Out? Pharmaceutical giant Pfizer’s (PFE) omicron-targeted booster doses could soon be authorized this fall. The company has benefited largely from the pandemic and its vaccine rollouts. Now let’s find out if PFE is a Buy now as it prepares to roll out its booster doses…. StockNews.com · Aug 26, 2022
Moderna sues Pfizer, BioNTech over COVID-19 vaccine The lawsuit seeks unspecified monetary damages for patent infringement. Axios · Aug 26, 2022
Tweaked COVID boosters close but how much will they help? COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help The Independent UK · Aug 25, 2022
How common is Paxlovid rebound as Jill Biden tests positive again for Covid? Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound The Independent UK · Aug 25, 2022
Study: Pfizer COVID pill showed no benefit in younger adults Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults The Independent UK · Aug 24, 2022
The Independent UK · Aug 24, 2022 How common is Paxlovid rebound as Jill Biden tests positive again for Covid? Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound
Los Angeles Times · Aug 24, 2022 A looming COVID risk in California? Schools return with fewer rules, lagging vaccine rates LOS ANGELES — California schools reopened for the fall semester with loosened COVID-19 protocols and low student vaccination rates among younger children, presenting a new test for the trajectory of the pandemic as some experts expect another rise in cases when winter arrives.
The Independent UK · Aug 23, 2022 Pfizer COVID shots appear 73% effective in children under 5 Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring
Benzinga · Aug 23, 2022 What Are Whales Doing With Pfizer A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 10 strange trades.
Tribune News Service · Aug 23, 2022 Pfizer’s shot is 73% effective against COVID in children under 5 Pfizer Inc.’s COVID-19 vaccine was 73.2% effective against the disease in a trial of children 6 months through 4 years old, reinforcing results that led to the shot’s authorization in young kids in June.
Tribune News Service · Aug 22, 2022 Pfizer files application for booster against latest variants Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.
WEKU · Aug 22, 2022 Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
The Independent UK · Aug 22, 2022 Pfizer seeks OK of updated COVID vaccine booster for fall Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives
Wales Online · Aug 20, 2022 Next phase of Covid jabs rollout starts next month Around 26m people across England eligible for autumn booster
Bangkok Post · Aug 19, 2022 Covid vaccine plan for the very young The government plans to buy 2.9 million doses of Covid-19 vaccine from Pfizer for children aged from six months to four years.
The Independent UK · Aug 18, 2022 Covid booster rollout of dual-strain jab to start on 5 September Moderna’s new dual-strain vaccine will be offered to millions of Britons ahead of winter